概览
The DIA India Annual Meeting (IAM) 2026 marks a defining moment for India’s life sciences and healthcare ecosystem. As science, technology, and regulation converge at unprecedented speed, IAM 2026 emerges as the platform where future-ready strategies are shaped, tested, and translated into real-world impact.
Bringing together global and Indian leaders from pharma, biotech, medical devices, regulators, academia, and technology, IAM 2026 goes beyond dialogue-it enables decision-making, collaboration, and action across the full product lifecycle.
With six deep-dive tracks and two high-impact plenary sessions, this year’s meeting reflects the expanding scope and complexity of modern healthcare, from advanced therapies and digital innovation to regulatory transformation, patient safety, and evidence generation. IAM 2026 is designed for leaders who are not just adapting to change, but shaping what comes next.
项目委员会
-
Chitra Lele Program Chair-DS Track, Managing Director, Life Sciences Consulting
NTT DATA, India -
Sanish Davis Program Chair-CD Track, Senior Medical Director, Clinical Science-Oncology
Takeda, India -
Gaurav Mathur Program Chair-RS Track, Senior Director, Regulatory Affairs
Parexel International, Bengaluru, India -
Vivek Ahuja Program Chair-PV Track, Executive Vice President, Pharmacovigilance
EVERSANA, India -
Subrat Ray Program Chair-MA Track, Director Global Medical Strategy
Organon (India) Pvt Ltd, India -
Sridevi Nagarajan AI Consortium Co Chair, Global Transformation Lead, Argenx
Ayusarogya, United Kingdom -
Praveen Raj Program Chair- AT Track, Medical Affairs Leader & Health Economics Expert
Biocon, India -
Ashok Kumar Swain General Manager, India
DIA, India -
Senthilnathan Mohanasundaram Country Head – Medical Affairs
Cipla Ltd, India -
Srirupa Das Vice President – Medical and Regulatory Affairs
Zydus Healthcare Ltd, India -
Shweta Pradhan Head India R&D Operations
IQVIA, India -
Anirban Roy Chowdhury AVP & Head- Development Center of Excellence Specialty Medicine
Sun Pharma, India -
Mukesh Kumar Chief Scientific Officer
CLINEXEL, India -
Manjusha Rajarshi Founder Regulus Healthcare
Partner at roots-simplified Research and Consulting LLP, India -
Sushant Kumar Head – R&D
Immunoadoptive Cell Therapy Pvt. Ltd. (ImmunoACT), India -
J Vijay Venkatraman Managing Director and CEO
Oviya Medsafe Pvt Ltd, India -
Prantika Khetarpal Pharmacovigilance Industry Leader,
Life Sciences, TCS, India -
Samuel Solomon Vice President Regulatory Affairs
Intas Pharmaceuticals, India -
Meenakshi Mudiraj Senior Director Global Regulatory Affairs
Teva Pharmaceuticals, India -
Prachet Mohanty Associate Director, Research & Development BI&T (WWPS & GRS)
Bristol Myers Squibb, India